Skip to content
You are now leaving https://www.ionispharma.com to visit

Akcea Therapeutics Announces Closing of Initial Public Offering

CAMBRIDGE, Mass. , July 19, 2017 /PRNewswire/ — Akcea Therapeutics, Inc. today announced the closing of its initial public offering of 17,968,750 shares common stock at a public offering price of $8.00 per share, including 2,343,750 shares of common stock issued upon full exercise by the